IOVA
Iovance BiotherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
IOVA vs peer average
28/100
IOVA vs. peer average (F vs. D)
Grade spread
A 1 · B 2 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Gilead, through Kite, is the closest commercial cell-therapy benchmark in the peer list; it is much larger, but it shows that manufacturing consistency and treatment-center execution can matter as much as efficacy after launch.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IOVA
Iovance Biotherapeutics
GILD
Gilead Sciences
Grade
F
B
Momentum
100
65
Value
41
66
Sentiment
2
63
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs GILD
IOVA / GILD
Grade Position
Below peers
IOVA vs. peer average (F vs. D)
28/100
Momentum
100
IOVAValue
41
GILDSentiment
2
GILDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IOVA
GILD is the first peer returned for this comparison set.